Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion
Not Applicable
- Conditions
- Drug Contamination
- Interventions
- Other: Re-filling of syringe with propofol without EDTAOther: Target controlled infusion of propofol without EDTAOther: Propofol syringe re-filling with propofol containing EDTA
- Registration Number
- NCT00757458
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
The purpose of this study is to verify the existence of bacterial and/or fungal contamination during different technics of propofol with or without EDTA continuous infusion in patients undergoing general anesthesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 652
Inclusion Criteria
- Age eighteen years old or more
- ASA Physiological Status P1 ou P2
- Patients undergoing clean procedure under general anesthesia.
Exclusion Criteria
- Patients under eighteen years old
- ASA Physiological Status P3, P4 or P5
- Current infectious process
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 3 Re-filling of syringe with propofol without EDTA Re-filling of propofol syringe (Diprivan®-Astra Zeneca) with propofol without EDTA 4 Target controlled infusion of propofol without EDTA Target controlled infusion of propofol without EDTA 1 EDTA without re-filling TCI with EDTA 2 Propofol syringe re-filling with propofol containing EDTA Re-filling of propofol syringe (Diprivan®-Astra Zeneca) with propofol containing EDTA
- Primary Outcome Measures
Name Time Method Existence of bacterial and/or fungal contamination during different technics of propofol continuous infusion 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Universidade de Sao Paulo Hospital das Clinicas
🇧🇷Sao Paulo, Brazil